Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Sequent Scientific Ltd.

NSE: SEQUENT | BSE:512529

₹131.69 -1.69 (-1.27%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

131.40

Today’s High

134.90

52W low

86.40

52W High

155.50

Open Price

134.20

Prev. Close

120.8000

Volume

1410456.00

Value

185742950.64

Fundamentals

Market Cap

3285.40

Price to Earnings

-91.60

Price to Book Value

4.60

Dividend Yield

0.00

PE to Growth

-1.30

Op Revenue TTM

1369.73

Net Profit TTM

-35.87

Cash From Operating Activity

30.59

Return on Equity %

-5.46

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

5Day EMA

128.2

10Day EMA

125.2

12Day EMA

124.4

20Day EMA

122.1

26Day EMA

121.1

50Day EMA

119.9

100Day EMA

119.9

200Day EMA

116.1

5Day SMA

127.7

10Day SMA

123.1

20Day SMA

122.7

30Day SMA

117.1

50Day SMA

117.6

100Day SMA

122.5

150Day SMA

124.2

200Day SMA

118

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

05 Jul, 2024

43.1

Week

38.7

Month

38.6

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

132.65

PIVOT

First Resistance

133.94

Second Resistance

136.20

Third Resistance

137.49

First Support

130.39

Second Support

129.10

Third Support

126.84

Relative Strength Index

66.04

Money Flow Index

84.47

MACD

3.34

MACD Signal

2.14

Average True Range

4.91

Average Directional Index

22.02

Rate of Change (21)

27.79

Rate of Change (125)

-0.23

Commodity Channel Index

227.9

Williams %R

-22.6

BETA

1 Month

1.24

3 Month

0.96

1 Year

0.75

3 Year

0.51

PRICE CHANGE ANALYSIS

↑ 12.62%

1 Week

Low

High

116.8

136.15

↑ 27.79%

1 Month

Low

High

104.65

136.15

↑ 0.99%

3 Months

Low

High

92.05

136.15

↑ 3.86%

6 Months

Low

High

92.05

155.5

↑ 44.95%

1 Year

Low

High

86.4

155.5

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 49.75 55.65 58.98 50.12 54.61 64.62 60.96 70.74 69.44 64.89 60.52
Operating Expenses Qtr 42.51 46.36 56.82 49.49 52.64 65.75 63.81 66.85 58.46 56.41 54.69
Operating Profit Qtr -5.74 -4.16 -7.70 -9.07 -6.04 -8.75 -9.58 -1.99 5.21 2.78 -4.58
EBIDT Qtr Cr 7.23 9.29 2.17 -5.63 1.97 -1.12 -2.85 3.89 10.99 8.48 5.83
Depreciation Qtr 2.11 2.05 2.35 2.42 2.33 2.15 2.25 2.38 2.34 2.40 2.54
Net Profit Qtr 3.76 4.58 -0.92 -6.80 -1.65 -1.23 -4.05 0.84 6.65 4.47 4.29
Basic EPS Qtr 0.15 0.18 -0.04 -0.27 -0.07 -0.05 -0.16 0.03 0.27 0.18 0.17
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 214.50 250.93 247.27 285.42 241.89
Operating Expenses Annual Cr 195.18 249.04 220.38 230.17 205.10
Operating Profit Annual -26.66 -26.36 -0.75 35.29 22.24
Operating Profit Margin Annual % -12.43 -10.51 -0.30 12.36 9.19
Total Expenses Annual Cr 208.48 260.67 231.58 241.97 219.08
EBIDT Annual Cr 19.32 1.88 26.89 55.26 36.80
EBIDT Annual margin % 9.01 0.75 10.88 19.36 15.21
Depreciation 8.94 9.12 9.59 9.13 8.95
PAT Before ExtraOrdinary Items Annual Cr 0.62 -6.08 14.80 32.11 21.34
Net Profit Annual 0.62 -6.08 14.80 32.11 21.34
Basic EPS Annual 0.03 -0.24 0.60 1.30 0.88
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 1087.23 1058.36 1031.95 1029.51 886.22
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 2.21 2.80 2.59 2.42 18.19
Total Current Liabilities Annual Cr 98.16 61.61 80.55 70.19 92.96
Total Capital Plus Liabilities Annual Cr 1187.60 1122.77 1124.23 1102.12 997.37
Fixed Assets Annual 47.66 58.92 68.31 70.12 73.13
Total Non Current Assets Annual 1082.42 1037.66 978.37 983.56 885.70
Total Current Assets Annual 105.18 85.12 145.86 118.56 111.67
Total Assets Annual 1187.60 1122.77 1124.23 1102.12 997.37
Contingent Liabilities plus Commitments Annual Cr - 266.31 247.44 0.99 0.64
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual -26.94 37.75 9.36 2.34 30.20
Cash from Investing Activity Annual 5.47 -50.70 -4.25 170.00 -10.38
Cash from Financing Annual Activity 22.32 0.24 7.25 -174.78 -18.01
Net Cash Flow Annual - -12.71 12.36 -2.44 1.81
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 43.59 42.43 41.55 41.45 35.68
ROE Annual % 0.05 -0.57 1.43 3.11 2.40
ROCE Annual % 0.95 -0.68 1.65 4.47 3.07
Total Debt to Total Equity Annual 0.04 0.02 0.01 0.01 0.03
EBDIT Annual Margin % 11.46 0.84 12.24 20.81 16.18
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 365.19 333.88 347.62 334.00 368.40 378.18 338.52 342.20 387.48 361.71 351.29
Operating Expenses Qtr 328.93 307.11 330.84 341.44 370.04 364.98 334.74 339.20 350.36 321.83 330.87
Operating Profit Qtr 32.27 22.25 15.13 -8.24 -3.37 10.34 2.87 2.12 33.35 36.22 19.68
EBIDT Qtr Cr 31.56 29.53 24.85 -30.95 -63.23 13.20 3.78 -0.20 37.12 39.89 20.41
Depreciation Qtr 16.48 15.46 15.36 14.24 14.71 13.67 13.38 12.56 12.47 12.83 13.21
Net Profit Qtr -0.91 8.27 -8.38 -34.85 -93.57 -8.87 -3.75 -14.05 8.96 17.12 14.30
Basic EPS Qtr -0.04 0.33 -0.34 -1.40 -3.77 -0.36 -0.15 -0.57 0.36 0.69 0.58
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 1380.69 1427.30 1423.66 1369.98 1189.33
Operating Expenses Annual Cr 1308.32 1408.95 1303.42 1149.55 1008.92
Operating Profit Annual 61.41 11.96 109.40 212.07 170.32
Operating Profit Margin Annual % 4.45 0.84 7.68 15.48 14.32
Total Expenses Annual Cr 1417.94 1500.16 1370.28 1224.53 1095.26
EBIDT Annual Cr 72.37 18.34 120.25 220.43 180.41
EBIDT Annual margin % 5.24 1.29 8.45 16.09 15.17
Depreciation 61.54 55.69 51.09 50.60 50.62
PAT Before ExtraOrdinary Items Annual Cr -29.61 -121.98 45.06 104.45 82.05
Net Profit Annual -35.87 -121.16 41.25 95.44 69.91
Basic EPS Annual -1.44 -4.88 1.65 3.85 2.85
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 656.56 698.78 683.27 727.65 742.76
Minority Interest Liability Annual Cr 56.40 50.41 48.01 48.66 44.74
Total Non Current Liabilities Annual Cr 200.44 253.87 188.96 155.34 261.21
Total Current Liabilities Annual Cr 626.99 526.07 512.12 460.90 469.60
Total Capital Plus Liabilities Annual Cr 1540.38 1529.12 1441.49 1392.56 1518.30
Fixed Assets Annual 321.42 420.55 381.29 392.25 407.68
Total Non Current Assets Annual 717.53 739.24 654.79 678.97 814.16
Total Current Assets Annual 822.86 789.89 786.70 713.59 704.14
Total Assets Annual 1540.38 1529.12 1441.49 1392.56 1518.30
Contingent Liabilities plus Commitments Annual Cr - 184.31 223.52 6.26 2.59
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 30.59 16.81 30.59 114.75 115.33
Cash from Investing Activity Annual -5.92 -64.96 -95.57 9.65 -72.27
Cash from Financing Annual Activity -1.44 32.23 67.26 -138.75 -42.75
Net Cash Flow Annual - -15.92 2.29 -14.35 0.31
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 28.58 30.04 29.44 31.26 31.71
ROE Annual % -5.46 -17.33 6.03 13.11 9.41
ROCE Annual % 1.18 -3.72 7.44 18.22 12.37
Total Debt to Total Equity Annual 0.69 0.57 0.46 0.27 0.38
EBDIT Annual Margin % 5.28 1.29 8.51 16.18 15.29
Name Holding Percent Holding Id Pledged % Locked %
Name Holding Percent Holding Id Pledged % Locked %
CA HARBOR INVESTMENTS 52.79 75047344 0 0
Name Holding Percent Holding Id
QUANT MUTUAL FUND - QUANT SMALL CAP FUND 4.79 75047347
ASHOKA WHITEOAK ICAV - ASHOKA WHITEOAK INDIA OPPOR 1.64 75047351
PUBLIC SECTOR PENSION INVESTMENT BOARD - IIFL ASSE 1.14 75047352
Name Holding Percent Holding Id
HUF 1.07 75047355
UNIT TRUST OF INDIA INVESTMENT ADVISORY SERVICES L 3.33 75047359
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Sep 08, 2021 0.5 FINAL Sep 10, 2021 Equity Share
Aug 21, 2019 0.2 FINAL - Equity Share
Nov 20, 2017 0.2 INTERIM Nov 21, 2017 Equity Share
Sep 16, 2011 1.5 FINAL - Equity Share
Sep 23, 2010 2 FINAL - Equity Share
Sep 02, 2009 1 FINAL - Equity Share
Sep 11, 2008 1 FINAL - Equity Share
Sep 13, 2007 1 FINAL - Equity Share
Ex-Date Split Ratio Record Date
Feb 25, 2016 10:2 -
Ex-Date Purpose Notes
May 15, 2024 Audited Results & Final Dividend -
Feb 13, 2024 Quarterly Results -
Nov 06, 2023 Quarterly Results -
Aug 10, 2023 Quarterly Results -
May 23, 2023 Audited Results & Dividend -
Feb 14, 2023 Quarterly Results -
Nov 07, 2022 Quarterly Results & Preferential issue -
Aug 08, 2022 Quarterly Results -
May 25, 2022 Audited Results -
Feb 11, 2022 Quarterly Results -
Nov 01, 2021 Quarterly Results -
Aug 10, 2021 Quarterly Results -
Jun 30, 2021 Audited Results & Final Dividend -
Feb 03, 2021 Quarterly Results -
Nov 06, 2020 Quarterly Results -
Jul 30, 2020 Quarterly Results -
May 12, 2020 Audited Results -
Jan 28, 2020 Quarterly Results -
Nov 13, 2019 Quarterly Results -
Jul 31, 2019 Quarterly Results -
May 14, 2019 Audited Results & Dividend -
Feb 01, 2019 Quarterly Results -
Nov 02, 2018 Quarterly Results -
Aug 09, 2018 Quarterly Results -
May 24, 2018 Audited Results & Dividend -
Feb 09, 2018 Quarterly Results -
Nov 09, 2017 Quarterly Results & Interim Dividend -
Aug 03, 2017 Quarterly Results -
May 23, 2017 Audited Results & Dividend -
Feb 10, 2017 Quarterly Results -
Nov 10, 2016 Quarterly Results -
Aug 12, 2016 Quarterly Results -
May 14, 2016 Audited Results & Dividend -
Feb 11, 2016 Quarterly Results Inducted Mr. K E C Raja Kumar as an Additional Director (Non-Executive) on the Board of the Company.
Oct 29, 2015 Quarterly Results Approved the sub-division (stock split) of one equity share of the Company having a face value of Rs. 10/- each into five equity shares of face value of Rs. 2/- each.
Jul 30, 2015 Quarterly Results -
Jun 10, 2015 Others Allotted 800,000 equity shares at Rs. 222.15 per share and 200,000 equity shares at Rs. 236 per share to M/s. Chayadeep Ventures LLP.
May 22, 2015 Others Approved the issue price of Rs. 535/- per Equity Share to be allotted to qualified institutional buyers through the QIP.
Apr 24, 2015 Audited Results & Dividend -
Nov 12, 2014 Quarterly Results -
Aug 13, 2014 Quarterly Results -
May 28, 2014 Audited Results & Dividend -
Feb 12, 2014 Quarterly Results -
Nov 13, 2013 Quarterly Results -
Aug 14, 2013 Quarterly Results -
May 30, 2013 Audited Results & Dividend -
Feb 14, 2013 Quarterly Results -
Nov 07, 2012 Quarterly Results To change the registerd office.
Aug 14, 2012 Quarterly Results -
May 24, 2012 Audited Results & Dividend -
Feb 09, 2012 Quarterly Results -
Oct 21, 2011 Quarterly Results -
Aug 12, 2011 Quarterly Results -
May 27, 2011 Audited Results & Dividend (Revised)
Feb 10, 2011 Quarterly Results -
Oct 29, 2010 Quarterly Results -
Aug 13, 2010 Quarterly Results -
May 28, 2010 Audited Results & Dividend -
Mar 29, 2010 Employees Stock Option Plan & Others To allot 700000 Equity Shares of Rs. 10/- each to M/s. SEQUENT SCIENTIFIC EMPLOYEE STOCK OPTION PLAN TRUST as created to implement the ESOP & to differ the decision on amalgamation of SRL with Co.
Jan 27, 2010 Quarterly Results -
Oct 29, 2009 Quarterly Results (Revised)
Sep 22, 2009 Scheme of Amalgamation The Board considered pursuant to the SoA of M/s. Sequent Scientific Ltd. with the Company 10,150,000 equity shares of Rs. 10/- each were allotted to the Shareholders of M/s. Sequent Scientific Ltd.
Sep 16, 2009 Issue & Allotment of Securities -
Jul 31, 2009 Quarterly Results -
Jun 22, 2009 Audited Results & Dividend -
Jan 30, 2009 Quarterly Results -
Oct 22, 2008 Quarterly Results -
Jul 29, 2008 Quarterly Results & Amalgamation To acquire Sequent Scientific Ltd by way of an amalgamation of Sequent into itself & to recommend a merger ratio to the Board to enable it to present the same to stock exchange. (Revised)
Jun 27, 2008 Audited Results & Dividend -
Jan 29, 2008 Quarterly Results -
Oct 25, 2007 Quarterly Results -
Jul 23, 2007 Quarterly Results -
Jun 20, 2007 Audited Results & Dividend -
Jan 31, 2007 Quarterly Results -
Oct 30, 2006 Quarterly Results -
Sep 07, 2006 Accounts -
Jul 31, 2006 Quarterly Results -
Apr 30, 2006 Quarterly Results -
Apr 20, 2006 Issue of warrants on preferential basis Acquisition of another unlisted Company engaged in similar line of pharma business & Reclassification of authorised capital of the Company
Jan 30, 2006 Quarterly Results -
Oct 29, 2005 Quarterly Results -
Jul 30, 2005 Quarterly Results -
Apr 30, 2005 Quarterly Results & Others To consider to redeem Cumulative Optional Convertible Preference Shares alloted pursuant to the Scheme of Amalgamation.
Jan 31, 2005 Quarterly Results -
Aug 18, 2004 Dividend & Accounts -
Apr 29, 2004 Quarterly Results -
Jan 30, 2004 Quarterly Results -
Nov 20, 2003 Others To give effect to the various clauses of the Scheme of Amalgamation of M/s P.I.Drugs & Pharmaceuticals Ltd with the company as sanctioned by the High Court.
Oct 31, 2003 Quarterly Results -
Jul 31, 2003 Quarterly Results -
Jan 31, 2003 Quarterly Results -
Jan 03, 2003 Others To consider the report of the commitee of Directors in respect of acquisition of business of P.I. Drugs & Pharmaceuticals Ltd.
Dec 09, 2002 Others Feasibility of acquisition of P.I.Drugs & Pharmaceuticals Ltd. and manner of such acquisition & resolved on the steps to be taken.
Oct 14, 2002 Quarterly Results -
Jun 28, 2002 Accounts & Dividend -
Jan 30, 2002 Quarterly Results -
Ex-Date Bonus Ratio Record Date
Bigul
05 Jul 2024

SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
Bigul
28 Jun 2024

SEQUENT SCIENTIFIC LTD. - 512529 - Closure of Trading Window

 Closure of trading window
18 Jun 2024

Sequent Scientific - Worst Of The Disruption, Price Compression Behind: Yes Securities

 Upgrade to Add with triggers spread out
Bigul
14 Jun 2024

SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the earnings call and earnings presentation made on May 16, 2024, on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2024, is available on the Company's website.
Bigul
14 Jun 2024

SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Notice of postal ballot: Commencement of E-voting from 9;00 a.m. 13-06-2024 and end of E-voting upto 5:00 p.m. 12-07-2024
Bigul
12 Jun 2024

SEQUENT SCIENTIFIC LTD. - 512529 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

 Notice of postal ballot for Regularisation of appointment of Mr. Vedprakash Ragate (DIN:10578409) as Director (Executive ,Non-Independent) of the Company.
Bigul
30 May 2024

SEQUENT SCIENTIFIC LTD. - 512529 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Annual Secretarial Compliance Report FY 2023-24
Bigul
22 May 2024

SEQUENT SCIENTIFIC LTD. - 512529 - Re-Submission Of Outcome Dated February 05, 2024

 Re-submission of outcome dated February 05, 2024
Bigul
20 May 2024

SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Earning Call Transcript for the quarter and year ended March 31, 2024
Bigul
17 May 2024

SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Extract of audited Financial Result- Copy of newspaper advertisement.
See all News

FAQs

The latest market price of Sequent Scientific Ltd. on NSE was Rs. 131.69 as of today.

The opening share price of Sequent Scientific Ltd. was Rs. 134.20 as of today.

The 52-week high share price of Sequent Scientific Ltd. was Rs. 155.50.

The 52 week low share price of Sequent Scientific Ltd. was Rs. 86.40.

Please find Corporate actions section for more details.

The PE ratio of Sequent Scientific Ltd. is -1.30. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Sequent Scientific Ltd. was on 2021-09-08 for Rs. 0.5 per share. According to today’s share price, the dividend yield of Sequent Scientific Ltd. stands at 0.00. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

The latest split issue declared by Sequent Scientific Ltd. was as of 2016-02-25. The split ratio declared in this issue was 10:2. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Sequent Scientific Ltd..

Close

Let's Open Free Demat Account